214 related articles for article (PubMed ID: 26778620)
1. Dynamic Transmission Economic Evaluation of Infectious Disease Interventions in Low- and Middle-Income Countries: A Systematic Literature Review.
Drake TL; Devine A; Yeung S; Day NP; White LJ; Lubell Y
Health Econ; 2016 Feb; 25 Suppl 1(Suppl Suppl 1):124-39. PubMed ID: 26778620
[TBL] [Abstract][Full Text] [Related]
2. Economic Evaluation in Global Perspective: A Bibliometric Analysis of the Recent Literature.
Pitt C; Goodman C; Hanson K
Health Econ; 2016 Feb; 25 Suppl 1(Suppl Suppl 1):9-28. PubMed ID: 26804359
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Economic Evaluation Methods Across Low-income, Middle-income and High-income Countries: What are the Differences and Why?
Griffiths UK; Legood R; Pitt C
Health Econ; 2016 Feb; 25 Suppl 1(Suppl Suppl 1):29-41. PubMed ID: 26775571
[TBL] [Abstract][Full Text] [Related]
4. Foreword: Health Economic Evaluations in Low- and Middle-income Countries: Methodological Issues and Challenges for Priority Setting.
Pitt C; Vassall A; Teerawattananon Y; Griffiths UK; Guinness L; Walker D; Foster N; Hanson K
Health Econ; 2016 Feb; 25 Suppl 1(Suppl Suppl 1):1-5. PubMed ID: 26804357
[No Abstract] [Full Text] [Related]
5. Critical issues in the economic evaluation of interventions against communicable diseases.
Hutubessy RC; Bendib LM; Evans DB
Acta Trop; 2001 Mar; 78(3):191-206. PubMed ID: 11311183
[TBL] [Abstract][Full Text] [Related]
6. Incorporating Demand and Supply Constraints into Economic Evaluations in Low-Income and Middle-Income Countries.
Vassall A; Mangham-Jefferies L; Gomez GB; Pitt C; Foster N
Health Econ; 2016 Feb; 25 Suppl 1(Suppl Suppl 1):95-115. PubMed ID: 26786617
[TBL] [Abstract][Full Text] [Related]
7. What is the economic evidence for mHealth? A systematic review of economic evaluations of mHealth solutions.
Iribarren SJ; Cato K; Falzon L; Stone PW
PLoS One; 2017; 12(2):e0170581. PubMed ID: 28152012
[TBL] [Abstract][Full Text] [Related]
8. On discount rates for economic evaluations in global health.
Haacker M; Hallett TB; Atun R
Health Policy Plan; 2020 Feb; 35(1):107-114. PubMed ID: 31625564
[TBL] [Abstract][Full Text] [Related]
9. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
[TBL] [Abstract][Full Text] [Related]
10. Use of DALYs in economic analyses on interventions for infectious diseases: a systematic review.
Oostvogels AJ; De Wit GA; Jahn B; Cassini A; Colzani E; De Waure C; Kretzschmar ME; Siebert U; Mühlberger N; Mangen MJ
Epidemiol Infect; 2015 Jul; 143(9):1791-802. PubMed ID: 25499823
[TBL] [Abstract][Full Text] [Related]
11. Methodological Issues to Consider When Collecting Data to Estimate Poverty Impact in Economic Evaluations in Low-income and Middle-income Countries.
Sweeney S; Vassall A; Foster N; Simms V; Ilboudo P; Kimaro G; Mudzengi D; Guinness L
Health Econ; 2016 Feb; 25 Suppl 1(Suppl Suppl 1):42-52. PubMed ID: 26774106
[TBL] [Abstract][Full Text] [Related]
12. Identifying priority technical and context-specific issues in improving the conduct, reporting and use of health economic evaluation in low- and middle-income countries.
Luz A; Santatiwongchai B; Pattanaphesaj J; Teerawattananon Y
Health Res Policy Syst; 2018 Feb; 16(1):4. PubMed ID: 29402314
[TBL] [Abstract][Full Text] [Related]
13. Evaluations of training and education interventions for improved infectious disease management in low-income and middle-income countries: a systematic literature review.
van Dorst PWM; van der Pol S; Salami O; Dittrich S; Olliaro P; Postma M; Boersma C; van Asselt ADI
BMJ Open; 2022 Feb; 12(2):e053832. PubMed ID: 35190429
[TBL] [Abstract][Full Text] [Related]
14. Option B+ for the prevention of mother-to-child transmission of HIV infection in developing countries: a review of published cost-effectiveness analyses.
Karnon J; Orji N
Health Policy Plan; 2016 Oct; 31(8):1133-41. PubMed ID: 27016949
[TBL] [Abstract][Full Text] [Related]
15. Methods for economic evaluation alongside a multicentre trial in developing countries: a case study from the WHO Antenatal Care Randomised Controlled Trial.
Mugford M; Hutton G; Fox-Rushby J
Paediatr Perinat Epidemiol; 1998 Oct; 12 Suppl 2():75-97. PubMed ID: 9805724
[TBL] [Abstract][Full Text] [Related]
16. Economic Evaluation of Family Planning Interventions in Low and Middle Income Countries; A Systematic Review.
Zakiyah N; van Asselt AD; Roijmans F; Postma MJ
PLoS One; 2016; 11(12):e0168447. PubMed ID: 27992552
[TBL] [Abstract][Full Text] [Related]
17. Simple Inclusion of Complex Diagnostic Algorithms in Infectious Disease Models for Economic Evaluation.
Dodd PJ; Pennington JJ; Bronner Murrison L; Dowdy DW
Med Decis Making; 2018 Nov; 38(8):930-941. PubMed ID: 30403578
[TBL] [Abstract][Full Text] [Related]
18. Economic evaluation of HIV pre-exposure prophylaxis strategies: protocol for a methodological systematic review and quantitative synthesis.
Thavorn K; Kugathasan H; Tan DHS; Moqueet N; Baral SD; Skidmore B; MacFadden D; Simkin A; Mishra S
Syst Rev; 2018 Mar; 7(1):47. PubMed ID: 29544530
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
